Wells Fargo’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.2K | Buy |
|
|||||
|
2025
Q1 | $7.02K | Hold |
|
|||||
|
2024
Q4 | $11.4K | Hold |
|
|||||
|
2024
Q3 | $5.28K | Hold |
|
|||||
|
2024
Q2 | $5.05K | Sell |
|
|||||
|
2024
Q1 | $32.1K | Buy |
|
|||||
|
2023
Q4 | $21.1K | Buy |
|
|||||
|
2023
Q3 | $125K | Sell |
|
|||||
|
2023
Q2 | $334K | Buy |
|
|||||
|
2023
Q1 | $139K | Buy |
|
|||||
|
2022
Q4 | $119K | Buy |
|
|||||
|
2022
Q3 | $97K | Sell |
|
|||||
|
2022
Q2 | $89K | Sell |
|
|||||
|
2022
Q1 | $686K | Buy |
|
|||||
|
2021
Q4 | $477K | Sell |
|
|||||
|
2021
Q3 | $2.17M | Buy |
|
|||||
|
2021
Q2 | $20K | Sell |
|
|||||
|
2021
Q1 | $35K | Sell |
|
|||||
|
2020
Q4 | $213K | Buy |
|
|||||
|
2020
Q3 | $4K | Sell |
|
|||||
|
2020
Q2 | $3K | Sell |
|
|||||
|
2020
Q1 | $54K | Buy |
|
|||||
|
2019
Q4 | $49K | Sell |
|
|||||
|
2019
Q3 | $34K | Buy |
|
|||||
|
2019
Q2 | $54K | Sell |
|
|||||
|
2019
Q1 | $184K | Buy |
|
|||||
|
2018
Q4 | $201K | Buy |
|
|||||
|
2018
Q3 | $229K | Buy |
|
|||||
|
2018
Q2 | $297K | Sell |
|
|||||
|
2018
Q1 | $269K | Buy |
|
|||||
|
2017
Q4 | $376K | Sell |
|
|||||
|
2017
Q3 | $1.08M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Buy |
|
|||||
|
2017
Q1 | $369K | Buy |
|
|||||
|
2016
Q4 | $175K | Buy |
|
|||||
|
2016
Q3 | $84K | Buy |
|
|||||
|
2016
Q2 | $30K | Sell |
|
|||||
|
2016
Q1 | $30K | Buy |
|
|||||
|
2015
Q4 | $45K | Buy |
|